Colestipol overdosage

Revision as of 05:36, 11 February 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{colestipol}} {{CMG}}; {{AE}} {{SS}} ==Overdosage== Overdosage of COLESTID Granules or FLAVORED COLESTID Granules has not been reported. Should overdosage occur, h...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Colestipol
COLESTID® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Colestipol
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Overdosage

Overdosage of COLESTID Granules or FLAVORED COLESTID Granules has not been reported. Should overdosage occur, however, the chief potential harm would be obstruction of the gastrointestinal tract. The location of such potential obstruction, the degree of obstruction and the presence or absence of normal gut motility would determine treatment.[1]


References

  1. "COLESTID (COLESTIPOL HYDROCHLORIDE) GRANULE, FOR SUSPENSION FLAVORED COLESTID (COLESTIPOL HYDROCHLORIDE) GRANULE, FOR SUSPENSION [PHARMACIA AND UPJOHN COMPANY]". Retrieved 11 February 2014.

Template:Lipid modifying agents